Zheng, Z.N. et al. 2026. Advances in Targeted Therapy for Human Epidermal Growth Factor Receptor 2-Low Tumors: From Trastuzumab to Antibody-Drug Conjugates. World Journal of Oncology. 17, 2 (Jan. 2026), 129–142. DOI:https://doi.org/10.14740/wjon2718.